Paracetamol (Acetaminophen): Mechanisms of action

Paediatric Anaesthesia

Volumn 18, Issue 10, 2008, Pages 915-921

  Anderson, Brian J ^a,b  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Acetaminophen; Cannabinoid; Cyclooxygenase; Paracetamol; Prostaglandin endoperoxide synthases; Serotonergic

Indexed keywords

4 AMINOPHENOL; ARACHIDONIC ACID; CANNABINOID RECEPTOR; FATTY ACID AMIDASE; GRANISETRON; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PEROXIDASE; PROSTAGLANDIN G2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE; PROTOPORPHYRIN; SEROTONIN 3 RECEPTOR; THROMBOXANE A2; TROPISETRON; TYROSINE;

ARACHIDONIC ACID METABOLISM; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SEROTONINERGIC SYSTEM;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; HUMANS; NITRIC OXIDE; NOCICEPTORS; PEROXIDASE; PROSTAGLANDIN H2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, CANNABINOID; RECEPTORS, PROSTAGLANDIN;

EID: 51349134126     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2008.02764.x     Document Type: Review

References (48)

1. Committee on Infectious Disease AAoP. Aspirin and Reye's syndrome. Pediatrics 1982 69 : 810.
2. Bjorkman R, Hallman KM, Hedner J et al. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 1994 57 : 259 264.
3. Bujalska M. Effect of nitric oxide synthase inhibition on antinociceptive action of different doses of acetaminophen. Pol J Pharmacol 2004 56 : 605 610.
4. Hunskaar S, Fasmer OB, Hole K. Acetylsalicylic acid, paracetamol and morphine inhibit behavioral responses to intrathecally administered substance P or capsaicin. Life Sci 1985 37 : 1835 1841.
5. Pickering G, Esteve V, Loriot MA et al. Acetaminophen reinforces descending inhibitory pain pathways. Clin Pharmacol Ther 2008 84 : 47 51.
6. Hogestatt ED, Jonsson BA, Ermund A et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 2005 280 : 31405 31412.
7. Ottani A, Leone S, Sandrini M et al. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol 2006 531 : 280 281.
8. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther 2005 12 : 46 55.
9. Bertolini A, Ferrari A, Ottani A et al. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006 12 : 250 275.
10. Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 2006 79 : 9 19.
11. Herrero JF, Romero-Sandoval EA, Gaitan G et al. Antinociception and the new COX inhibitors: research approaches and clinical perspectives. CNS Drug Rev 2003 9 : 227 252.
12. Kis B, Snipes JA, Busija DW. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther 2005 315 : 1 7.
13. Piletta P, Porchet HC, Dayer P. Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther 1991 49 : 350 354.
14. Bannwarth B, Netter P, Lapicque F et al. Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol 1992 34 : 79 81.
15. Anderson BJ, Holford NHG, Woollard GA et al. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol 1998 46 : 237 243.
16. Anderson BJ, Woollard GA, Holford NH. Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy. Eur J Clin Pharmacol 2001 57 : 559 569.
17. Pelissier T, Alloui A, Caussade F et al. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine 3 receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther 1996 278 : 8 14.
18. Tjolsen A, Lund A, Hole K. Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol 1991 193 : 193 201.
19. Alloui A, Chassaing C, Schmidt J et al. Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol 2002 443 : 71 77.
20. Pickering G, Loriot MA, Libert F et al. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther 2006 79 : 371 378.
21. Nakamura K, Li YQ, Kaneko T et al. Prostaglandin EP3 receptor protein in serotonin and catecholamine cell groups: a double immunofluorescence study in the rat brain. Neuroscience 2001 103 : 763 775.
22. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991 14 : 219 245.
23. Tork I. Anatomy of the serotonergic system. Ann N Y Acad Sci 1990 600 : 9 34.
24. Chandrasekharan NV, Simmons DL. The cyclooxygenases. Genome Biol 2004 5 : 241.
25. Chandrasekharan NV, Dai H, Roos KL et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002 99 : 13926 13931.
26. Gupta K, Selinsky BS, Kaub CJ et al. The 2.0 A resolution crystal structure of prostaglandin H2 synthase-1: structural insights into an unusual peroxidase. J Mol Biol 2004 335 : 503 518.
27. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000 69 : 145 182.
28. Rowlinson SW, Kiefer JR, Prusakiewicz JJ et al. A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem 2003 278 : 45763 45769.
29. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972 240 : 410 411.
30. Warner TD, Mitchell JA. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc Natl Acad Sci USA 2002 99 : 13371 13373.
31. Kramer MS, Naimark LE, Roberts Brauer R et al. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet 1991 337 : 591 594.
32. Autret E, Reboul Marty J, Henry Launois B et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. Eur J Clin Pharmacol 1997 51 : 367 371.
33. Middleton RS. Double blind trial in general practice comparing the efficacy of 'Benylin Day and Night' and paracetamol in the treatment of the common cold. Br J Clin Pract 1981 35 : 297 300.
34. Bisogno T. Endogenous cannabinoids: structure and metabolism. J Neuroendocrinol 2008 20 (Suppl 1 1 9.
35. Guhring H, Hamza M, Sergejeva M et al. A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 2002 454 : 153 163.
36. Kelley BG, Thayer SA. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. Eur J Pharmacol 2004 496 : 33 39.
37. Zygmunt PM, Chuang H, Movahed P et al. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 2000 396 : 39 42.
38. Ovadia H, Wohlman A, Mechoulam R et al. Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 1995 34 : 175 180.
39. Inoue T, Mashimo T, Shibata M et al. Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model. Brain Res 1998 792 : 263 270.
40. Meller ST, Dykstra C, Gebhart GF. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur J Pharmacol 1992 214 : 93 96.
41. Bjorkman R. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiol Scand Suppl 1995 103 : 1 44.
42. Keeble JE, Moore PK. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol 2002 137 : 295 310.
43. Fiorucci S, Santucci L, Distrutti E. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon. Dig Liver Dis 2007 39 : 1043 1051.
44. Sousa AM, Prado WA. The dual effect of a nitric oxide donor in nociception. Brain Res 2001 897 : 9 19.
45. Rameau GA, Chiu LY, Ziff EB. Bidirectional regulation of neuronal nitric-oxide synthase phosphorylation at serine 847 by the N-methyl-D-aspartate receptor. J Biol Chem 2004 279 : 14307 14314.
46. Deeb RS, Resnick MJ, Mittar D et al. Tyrosine nitration in prostaglandin H(2) synthase. J Lipid Res 2002 43 : 1718 1726.
47. Deeb RS, Shen H, Gamss C et al. Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol 2006 168 : 349 362.
48. Deeb RS, Hao G, Gross SS et al. Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite. J Lipid Res 2006 47 : 898 911.